Gordon E. Moore - Director, Gilead Sciences Inc

As of August 16, 2012


Gordon E. Moore Net Worth

  • Net worth is estimated to be at least $9.23B
  • Owns at least 571,839 units of Gilead Sciences Inc stock
  • Sold an estimated value of $5.13M in the last 8 years at Gilead Sciences Inc

Gordon E. Moore Trading

  • Largest purchase of shares was 144,000 units , worth over $487.14K on August 11, 2009
  • Largest sale of shares was 110,817 units , worth over $5.1M on August 11, 2009
  • In total has made about 22 transactions over 8 years
  • Usually trades in May, with the busiest year in 2004, 2010, 2012 and 2007
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Gilead Sciences Inc Insider Trading

  • The most recent transaction was 13,610 units sold on August 18, 2021 by Diane E Wilfong worth over $986.73K
  • In the last 18 years, insiders at Gilead Sciences Inc sold an estimated value of $2.75B and bought an estimated value of $523.75M
  • The most active traders are Gregg H Alton, Chief Patient Officer,  John C Martin, Director,  and John F Milligan, President and CEO
  • Insider trading is most common in May, with the busiest year in 2014 and 2015

GILEAD SCIENCES INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1